Combination of Ibrutinib and As2O3 in the Treatment of CLL
Peking University People's Hospital
Peking University People's Hospital
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
H. Lee Moffitt Cancer Center and Research Institute
Northwestern University
SCRI Development Innovations, LLC